Seminars in Roentgenology
Volume 42, Issue 4 , Pages 253-264 , October 2007

Lymph Node Status in the Breast Cancer Patient: Sampling Techniques and Prognostic Significance

  • Beatriz B. Amaral, MD

      Affiliations

    • Radimagem Diagnostic Imaging, Porto Alegre, Brazil.
    • Corresponding Author InformationAddress correspondence to Beatriz B. Amaral, MD, Radimagem, Av. Cristóvão Colombo, 1691, Porto Alegre, RS 90560-004, Brazil.
    • ,
  • Luise Meurer, MD, PhD

      Affiliations

    • Medicina Digital; Pathology Department, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
    • ,
  • Gary J. Whitman, MD

      Affiliations

    • Division of Diagnostic Imaging, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.
    • ,
  • Jessica W.T. Leung, MD

      Affiliations

    • Department of Radiology, University of California San Francisco Medical Center, San Francisco, California.

References 

  1. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456–466
  2. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399
  3. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335–339discussion 340
  4. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391–398discussion 398-401
  5. Society AC: Breast Cancer Facts & Figures 2005-2006. 2005
  6. Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer (Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening). Arch Surg. 1996;131:301–308
  7. Tabar L, Duffy SW, Vitak B, et al. The natural history of breast carcinoma: what have we learned from screening?. Cancer. 1999;86:449–462
  8. Rivadeneira DE, Simmons RM, Christos PJ, et al. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg. 2000;191:1–6discussion 6-8
  9. Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer. 1992;66:136–138
  10. Kissin MW, Querci della Rovere G, Easton D, et al. Risk of lymphoedema following the treatment of breast cancer. Br J Surg. 1986;73:580–584
  11. Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg. 1993;36:315–320
  12. Tanis PJ, Nieweg OE, Valdes Olmos RA, et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg. 2001;192:399–409
  13. Spratt JS. Anatomy of the breast. Major Probl Clin Surg. 1967;5:1–11
  14. Turner-Warwick RT. The lymphatics of the breast. Br J Surg. 1959;46:574–582
  15. Julian TB, Krag D, Brown A, et al. Preliminary technical results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients. Breast Cancer Res Treat. 2004;(suppl 11):(abstr 14)
  16. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–553
  17. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609
  18. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1998;339:941–946
  19. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345–2350
  20. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–651discussion 651-643
  21. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560–2566
  22. Posther KE, Wilke LG, Giuliano AE. Sentinel lymph node dissection and the current status of American trials on breast lymphatic mapping. Semin Oncol. 2004;31:426–436
  23. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–7720
  24. Kuerer HM, Newman LA. Lymphatic mapping and sentinel lymph node biopsy for breast cancer: developments and resolving controversies. J Clin Oncol. 2005;23:1698–1705
  25. Noguchi M. Current controversies concerning sentinel lymph node biopsy for breast cancer. Breast Cancer Res Treat. 2004;84:261–271
  26. Cody HS. Sentinel lymph node biopsy for breast cancer: does anybody not need one?. Ann Surg Oncol. 2003;10:1131–1132
  27. Bedrosian I, Reynolds C, Mick R, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer. 2000;88:2540–2545
  28. Chung MH, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol. 2001;8:688–692
  29. Goyal A, Newcombe RG, Chhabra A, et al. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203–208
  30. Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet. 1981;152:765–772
  31. Specht MC, Fey JV, Borgen PI, et al. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?. J Am Coll Surg. 2005;200:10–14
  32. Bleiweiss IJ. Sentinel lymph nodes in breast cancer after 10 years: rethinking basic principles. Lancet Oncol. 2006;7:686–692
  33. Tousimis E, Van Zee KJ, Fey JV, et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg. 2003;197:529–535
  34. Jin Kim H, Heerdt AS, Cody HS, et al. Sentinel lymph node drainage in multicentric breast cancers. Breast J. 2002;8:356–361
  35. Cody HS. Reoperative sentinel lymph node biopsy: Adding nuance to the management of locally recurrent breast cancer. Ann Surg Oncol. 2006;
  36. Taback B, Nguyen P, Hansen N, et al. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol. 2006;13:1099–1104
  37. Intra M, Trifiro G, Viale G, et al. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol. 2005;12:895–899
  38. Port ER, Fey J, Gemignani ML, et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg. 2002;195:167–172
  39. Haigh PI, Hansen NM, Qi K, et al. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol. 2000;7:21–27
  40. Wong SL, Edwards MJ, Chao C, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol. 2002;9:272–277
  41. Liberman L, Cody HS. Percutaneous biopsy and sentinel lymphadenectomy: minimally invasive diagnosis and treatment of nonpalpable breast cancer. AJR Am J Roentgenol. 2001;177:887–891
  42. Golshan M, Lesnikoski BA, Lester S. Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery. Am Surg. 2006;72:397–400
  43. Jakub JW, Ebert MD, Cantor A, et al. Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping. Plast Reconstr Surg. 2004;114:1737–1742
  44. Dupont EL, Kuhn MA, McCann C, et al. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg. 2000;180:274–277
  45. Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000;18:3480–3486
  46. Mamounas EP. Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg Clin North Am. 2003;83:931–942
  47. Buchholz TA, Hunt KK, Whitman GJ, et al. Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks. Cancer. 2003;98:1150–1160
  48. Stearns V, Ewing CA, Slack R, et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol. 2002;9:235–242
  49. Kell MR, Morrow M. Surgical aspects of inflammatory breast cancer. Breast Dis. 2005;22:67–73
  50. Sabel MS, Schott AF, Kleer CG, et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg. 2003;186:102–105
  51. Cody HS, Klauber-Demore N, Borgen PI, et al. Is it really duct carcinoma in situ?. Ann Surg Oncol. 2001;8:617–619
  52. Intra M, Zurrida S, Maffini F, et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol. 2003;10:1160–1165
  53. Intra M, Veronesi P, Mazzarol G, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg. 2003;138:309–313
  54. Yen TW, Hunt KK, Ross MI, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg. 2005;200:516–526
  55. Gentilini O, Cremonesi M, Trifiro G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol. 2004;15:1348–1351
  56. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004;240:462–468discussion 468-471
  57. Veronesi U, Galimberti V, Mariani L, et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer. 2005;41:231–237
  58. Cox C, White L, Allred N, et al. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol. 2006;13:708–711
  59. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet. 1997;349:1668–1669
  60. Pelosi E, Bello M, Giors M, et al. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. J Nucl Med. 2004;45:220–225
  61. Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002;95:385–388table of contents
  62. King TA, Fey JV, Van Zee KJ, et al. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann Surg Oncol. 2004;11:535–541
  63. Linehan DC, Hill AD, Tran KN, et al. Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. J Am Coll Surg. 1999;188:377–381
  64. Goldfarb LR, Alazraki NP, Eshima D, et al. Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99m sulfur colloid. Radiology. 1998;208:505–509
  65. Wilhelm AJ, Mijnhout GS, Franssen EJ. Radiopharmaceuticals in sentinel lymph-node detection—an overview. Eur J Nucl Med. 1999;26:S36–S42
  66. Xavier NL, Amaral BB, Cerski CT, et al. Sentinel lymph node identification and sampling in women with early breast cancer using 99m Tc labelled dextran 500 and patent blue V dye. Nucl Med Commun. 2001;22:1109–1117
  67. Mirzaei S, Rodrigues M, Hoffmann B, et al. Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer. Eur J Nucl Med Mol Imaging. 2003;30:874–878
  68. Edreira MM, Colombo LL, Perez JH, et al. In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification. Nucl Med Commun. 2001;22:499–504
  69. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med. 2005;35:116–128
  70. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001;42:1198–1215
  71. Tanis PJ, Valdes Olmos RA, Muller SH, et al. Lymphatic mapping in patients with breast carcinoma: reproducibility of lymphoscintigraphic results. Radiology. 2003;228:546–551
  72. Styblo T, Aarsvold JN, Grant SF, et al. Sentinel lymph nodes: optimizing success. Semin Roentgenol. 2001;36:261–269
  73. Liberman L, Cody HS, Hill AD, et al. Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer. Radiology. 1999;211:835–844
  74. Nieweg OE, Estourgie SH, van Rijk MC, et al. Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients. J Surg Oncol. 2004;87:153–156
  75. Noguchi M, Tsugawa K, Miwa K. Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol. 2000;73:75–80
  76. Law M, Chow LW, Kwong A, et al. Sentinel lymph node technique for breast cancer: radiation safety issues. Semin Oncol. 2004;31:298–303
  77. Nos C, Freneaux P, Guilbert S, et al. Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification?. Ann Surg Oncol. 2001;8:438–443
  78. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106:4–16
  79. In:  Greene FL,  Page DL,  Fleming ID, et al. editor. AJCC Cancer Staging Manual. (ed 6). New York, NY: Springer; 2002;p. 223–240
  80. Khan A, Sabel MS, Nees A, et al. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol. 2005;12:697–704
  81. Podkrajsek M, Music MM, Kadivec M, et al. Role of ultrasound in the preoperative staging of patients with breast cancer. Eur Radiol. 2005;15:1044–1050
  82. Bedrosian I, Bedi D, Kuerer HM, et al. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patient with breast cancer. Ann Surg Oncol. 2003;10:1025–1030
  83. Rizzatto G. Towards a more sophisticated use of breast ultrasound. Eur Radiol. 2001;11:2425–2435
  84. Altinyollar H, Dingil G, Berberoglu U. Detection of infraclavicular lymph node metastases using ultrasonography in breast cancer. J Surg Oncol. 2005;92:299–303
  85. Whitman GJ, Sheppard DG, Phelps MJ, et al. Breast cancer staging. Semin Roentgenol. 2006;41:91–104
  86. Feu J, Tresserra F, Fabregas R, et al. Metastatic breast carcinoma in axillary lymph nodes: in vitro US detection. Radiology. 1997;205:831–835
  87. Luciani A, Itti E, Rahmouni A, et al. Lymph node imaging: basic principles. Eur J Radiol. 2006;58:338–344
  88. Krishnamurthy S, Sneige N, Bedi DG, et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer. 2002;95:982–988
  89. Topal U, Punar S, Tasdelen I, et al. Role of ultrasound-guided core needle biopsy of axillary lymph nodes in the initial staging of breast carcinoma. Eur J Radiol. 2005;56:382–385
  90. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19 to 22, 2001 (Philadelphia, Pennsylvania). Hum Pathol. 2002;33:579–589
  91. Viale G, Mastropasqua MG, Maiorano E, et al. Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience. Virchows Arch. 2006;448:241–247
  92. Dowlatshahi K, Fan M, Anderson JM, et al. Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol. 2001;8:675–681
  93. Silverberg SG. Sentinel node processing: recommendations for pathologists. Am J Surg Pathol. 2002;26:383–385
  94. Cserni G, Amendoeira I, Apostolikas N, et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer (Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology). J Clin Pathol. 2004;57:695–701
  95. Cserni G. Evaluation of sentinel lymph nodes in breast cancer. Histopathology. 2005;46:697–702
  96. Cserni G. Complete sectioning of axillary sentinel nodes in patients with breast cancer (Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients). J Clin Pathol. 2002;55:926–931
  97. Torrenga H, Rahusen FD, Meijer S, et al. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol. 2001;54:550–552
  98. Viale G, Bosari S, Mazzarol G, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer. 1999;85:2433–2438
  99. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer. 2001;92:1378–1384
  100. Wilkinson EJ, Hause L. Probability in lymph node sectioning. Cancer. 1974;33:1269–1274
  101. Hartveit F. The routine histological investigation of axillary lymph nodes for metastatic breast cancer. J Pathol. 1984;143:187–191
  102. Turner RR, Giuliano AE, Hoon DS, et al. Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg. 2001;25:798–805
  103. ADASP recommendations for processing and reporting lymph node specimens submitted for evaluation of metastatic disease. Am J Surg Pathol. 2001;25:961–963
  104. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer. 2003;98:2740–2741
  105. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin. 2006;56:37–47
  106. Cserni G. Histopathologic examination of the sentinel lymph nodes. Breast J. 2006;12:S152–S156
  107. Roberts CA, Beitsch PD, Litz CE, et al. Interpretive disparity among pathologists in breast sentinel lymph node evaluation. Am J Surg. 2003;186:324–329
  108. Cote RJ, Peterson HF, Chaiwun B, et al. International Breast Cancer Study Group Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet. 1999;354:896–900
  109. Weinberg ES, Dickson D, White L, et al. Cytokeratin staining for intraoperative evaluation of sentinel lymph nodes in patients with invasive lobular carcinoma. Am J Surg. 2004;188:419–422
  110. Fortunato L, Amini M, Farina M, et al. Intraoperative examination of sentinel nodes in breast cancer: is the glass half full or half empty?. Ann Surg Oncol. 2004;11:1005–1010
  111. Menes TS, Tartter PI, Mizrachi H, et al. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol. 2003;10:1166–1170
  112. Rubio IT, Korourian S, Cowan C, et al. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol. 1998;5:689–694
  113. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864–1867
  114. Flett MM, Going JJ, Stanton PD, et al. Sentinel node localization in patients with breast cancer. Br J Surg. 1998;85:991–993
  115. Chao C, Wong SL, Ackermann D, et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg. 2001;182:609–615
  116. Holck S, Galatius H, Engel U, et al. False-negative frozen section of sentinel lymph node biopsy for breast cancer. Breast. 2004;13:42–48
  117. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628–3636
  118. Cserni G, Sapino A, Decker T. Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast. 2006;15:347–354
  119. Amin BD, Hoda SA. Minimal metastatic disease in sentinel lymph nodes in breast carcinoma: some modest proposals to refine criteria for “isolated tumor cells”. Adv Anat Pathol. 2006;13:185–189
  120. Cserni G, Gregori D, Merletti F, et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg. 2004;91:1245–1252
  121. Imoto S, Ochiai A, Okumura C, et al. Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining. Eur J Surg Oncol. 2006;
  122. Krauth JS, Charitansky H, Isaac S, et al. Clinical implications of axillary sentinel lymph node ‘micrometastases’ in breast cancer. Eur J Surg Oncol. 2006;32:400–404
  123. Kahn HJ, Hanna WM, Chapman JA, et al. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Breast J. 2006;12:294–301
  124. Mullenix PS, Brown TA, Meyers MO, et al. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer. Am J Surg. 2005;189:606–609discussion 609
  125. Susnik B, Frkovic-Grazio S, Bracko M. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up. Ann Surg Oncol. 2004;11:568–572
  126. Fournier K, Schiller A, Perry RR, et al. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg. 2004;239:859–863discussion 863-855
  127. Fant JS, Grant MD, Knox SM, et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol. 2003;10:126–130
  128. Lucignani G. Sentinel lymph node biopsy: vision, multicentre trials, professional and technological synergy. Eur J Nucl Med Mol Imaging. 2006;33:1238–1241
  129. Sanidas EE, Daskalakis M, Sbyrakis N, et al. Modifications of the learning curve guidelines for breast cancer sentinel node biopsy. Eur J Surg Oncol. 2005;31:357–363
  130. Maggard MA, Lane KE, O’Connell JB, et al. Beyond the clinical trials: how often is sentinel lymph node dissection performed for breast cancer?. Ann Surg Oncol. 2005;12:41–47
  131. http://www.rcseng.acuk/education/courses/new-start.html:

PII: S0037-198X(07)00044-2

doi: 10.1053/j.ro.2007.07.002

Seminars in Roentgenology
Volume 42, Issue 4 , Pages 253-264 , October 2007

Article Tools

* Image Usage & Resolution